By-health Co., Ltd.

SZSE:300146.SZ

17.73 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 6,838.3959,406.8147,861.4127,431.2786,094.9015,261.7994,350.7763,110.7952,309.1122,266.0431,704.9811,482.2421,066.692657.964346.081205.29141.85766.85
Cost of Revenue 2,278.022,926.5612,493.3152,521.8282,266.3581,800.6981,406.9221,024.145822.073764.211580.009523.274390.701235.821122.9775.52856.32730.794
Gross Profit 4,560.3746,480.2525,368.0974,909.453,828.5423,461.1022,943.8542,086.651,487.0391,501.8321,124.972958.968675.991422.143223.111129.76285.53136.056
Gross Profit Ratio 0.6670.6890.6830.6610.6280.6580.6770.6710.6440.6630.660.6470.6340.6420.6450.6320.6030.539
Reseach & Development Expenses 148.629169.37158.497150.299139.952126.041103.4977.26495.84586.03652.79844.22919.7636.8142.537000
General & Administrative Expenses 168.444144.05868.96481.436109.598110.992123.4483.17545.46329.80946.01741.51724.33718.68910.49620.23318.1058.033
Selling & Marketing Expenses 2,523.1713,215.8463,169.2492,478.441,818.4191,650.41,280.078973.267638.851618.609397.041317.017265.891180.85585.79345.80329.75810.832
SG&A 2,691.6154,207.4443,238.2122,559.8761,928.0171,761.3921,403.5181,056.442684.314648.417443.058358.534290.229199.54496.28966.03647.86318.865
Other Expenses 896.6250.775374.011346.364386.437320.07526.396.64525.0119.66139.0965.6283.1582.6040.4610.372-0.4-0.162
Operating Expenses 3,736.8694,411.6493,770.723,056.5392,454.4062,207.5081,754.4461,287.797884.768839.282577.89473.803366.985239.578116.75868.10149.11718.959
Operating Income 823.5052,068.6031,609.2992,026.7841,788.721,346.4231,102.597878.359635.83720.834554.107502.793331.727217.421107.45461.36834.94917.869
Operating Income Ratio 0.120.220.2050.2730.2930.2560.2530.2820.2750.3180.3250.3390.3110.330.310.2990.2460.267
Total Other Income Expenses Net 77.11127.329106.294151.218-20.034-1,771.29126.3911.74117.88619.12538.1334.801-0.5242.5050.448-0.013-0.484-2.189
Income Before Tax 900.6152,195.9311,704.7892,178.0021,768.686-424.8681,128.987885.004653.716739.959592.237503.209331.203219.925107.90161.35534.46515.68
Income Before Tax Ratio 0.1320.2330.2170.2930.29-0.0810.2590.2840.2830.3270.3470.3390.310.3340.3120.2990.2430.235
Income Tax Expense 252.752417.179293.525411.699224.59-9.823220.555118.198146.061119.61889.64281.52350.84933.4915.7959.1837.763.554
Net Income 652.8341,746.311,385.8511,753.9791,524.251-415.0461,002.185766.256535.212635.496502.595421.686280.354186.43592.10652.17226.70512.126
Net Income Ratio 0.0950.1860.1760.2360.25-0.0790.230.2460.2320.280.2950.2840.2630.2830.2660.2540.1880.181
EPS 0.391.030.821.030.96-0.280.690.520.370.440.390.320.210.140.0930.060.0370.39
EPS Diluted 0.391.030.821.030.96-0.280.690.520.370.440.380.320.210.140.0930.060.0370.39
EBITDA 1,174.892,487.751,959.262,415.1872,000.578-120.3961,309.017995.859764.409747.88590.637521.798355.971227.472112.93263.96535.47418.924
EBITDA Ratio 0.1720.2640.2490.3250.328-0.0230.3010.320.3310.330.3460.3520.3340.3460.3260.3120.250.283